Top

Reactions Weekly

Published in:

01-10-2023 | NSCLC | Case report

Pembrolizumab

Pericardial effusion, cardiac tamponade and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Country of occurrence, reporter country and primary source country not stated. Author's communication details not available. Abstract presented at CHEST 2023.

SCHEID Z, et al. A CASE OF STAGE IV NON-SMALL CELL LUNG CANCER MANAGEMENT IN THE MODERN ERA: HOW MUCH IS TOO MUCH?. Chest 164 (Suppl.): A4449, No. 4, Oct 2023. Available from: URL: http://doi.org/10.1016/j.chest.2023.07.2889 [abstract]

Title: Pembrolizumab
Pericardial effusion, cardiac tamponade and lack of efficacy: case report
Publication date: 01-10-2023
Publisher: Springer International Publishing
Keywords: NSCLC
NSCLC
Pericardiocentesis
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-48106-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pembrolizumab

Pericardial effusion, cardiac tamponade and lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Ferric-carboxymaltose

Olanzapine

Antineoplastics

Multiple drugs

Methotrexate

Multiple drugs